Comparison of Early and Late Conversion of Sirolimus in Experimental Model of Chronic Cyclosporine Nephropathy

Sirolimus (SRL) is a promising drug for replacing calcineurin inhibitors. We performed this study to determine the optimal time of conversion from cyclosporine (CsA) to SRL in an experimental model of chronic CsA nephropathy. Three separate studies were performed. In the first study, SRL was given t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jin Young, Ghee, Jung Yeon, Lim, Sun Woo, Piao, Shang Guo, Chung, Byung Ha, Yoon, Hye Eun, Hwang, Hyeon Seok, Choi, Bum Soon, Kim, Jin, Yang, Chul Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271289/
https://www.ncbi.nlm.nih.gov/pubmed/22323863
http://dx.doi.org/10.3346/jkms.2012.27.2.160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271289/
https://www.ncbi.nlm.nih.gov/pubmed/22323863
http://dx.doi.org/10.3346/jkms.2012.27.2.160

Ejemplares similares